390 related articles for article (PubMed ID: 16077032)
1. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism.
Salthun-Lassalle B; Traver S; Hirsch EC; Michel PP
Mol Pharmacol; 2005 Nov; 68(5):1214-24. PubMed ID: 16077032
[TBL] [Abstract][Full Text] [Related]
2. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
Hall JM; Morton IK
Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Ca2+ signaling in tachykinin-mediated contractile responses in swine trachea.
Lin YR; Kao PC; Chan MH
J Biomed Sci; 2005; 12(3):547-58. PubMed ID: 15971006
[TBL] [Abstract][Full Text] [Related]
5. Tachykinin receptor expression and function in human esophageal smooth muscle.
Kovac JR; Chrones T; Preiksaitis HG; Sims SM
J Pharmacol Exp Ther; 2006 Aug; 318(2):513-20. PubMed ID: 16714401
[TBL] [Abstract][Full Text] [Related]
6. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
7. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
8. Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.
Lördal M; Bränström R; Hellström PM
Br J Pharmacol; 1998 Jan; 123(1):63-70. PubMed ID: 9484855
[TBL] [Abstract][Full Text] [Related]
9. Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels.
Salthun-Lassalle B; Hirsch EC; Wolfart J; Ruberg M; Michel PP
J Neurosci; 2004 Jun; 24(26):5922-30. PubMed ID: 15229240
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of intracerebroventricularly injected tachykinins in the conscious saline-loaded rat: receptor characterization.
Yuan YD; Couture R
Br J Pharmacol; 1997 Mar; 120(5):785-96. PubMed ID: 9138683
[TBL] [Abstract][Full Text] [Related]
11. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms mediating substance P-induced contraction in the rat iris in vitro.
Grumann-Júnior A; Dias MA; Alves RV; Boteon JE; Calixto JB
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1861-70. PubMed ID: 10845610
[TBL] [Abstract][Full Text] [Related]
13. Substance P targets sympathetic control neurons in the paraventricular nucleus.
Womack MD; Morris R; Gent TC; Barrett-Jolley R
Circ Res; 2007 Jun; 100(11):1650-8. PubMed ID: 17495222
[TBL] [Abstract][Full Text] [Related]
14. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
15. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin-receptor-mediated depolarization of cortical neurons elicits an increase in glutamate release at excitatory synapses.
Stacey AE; Woodhall GL; Jones RS
Eur J Neurosci; 2002 Nov; 16(10):1896-906. PubMed ID: 12453053
[TBL] [Abstract][Full Text] [Related]
17. Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels.
Guerreiro S; Toulorge D; Hirsch E; Marien M; Sokoloff P; Michel PP
Mol Pharmacol; 2008 Oct; 74(4):980-9. PubMed ID: 18621927
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin receptor subtypes in the isolated guinea pig heart and their role in mediating responses to neurokinin A.
Chang Y; Hoover DB; Hancock JC; Smith FM
J Pharmacol Exp Ther; 2000 Jul; 294(1):147-54. PubMed ID: 10871306
[TBL] [Abstract][Full Text] [Related]
19. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
Elliott PJ; Mason GS; Stephens-Smith M; Hagan RM
Neuropeptides; 1991 Jun; 19(2):119-26. PubMed ID: 1719444
[TBL] [Abstract][Full Text] [Related]
20. Tachykinin-depolarizations mediated by neurokinin-3 receptors in the hamster submandibular ganglion cells.
Yamada T; Endoh T; Suzuki T
Bull Tokyo Dent Coll; 1998 May; 39(2):123-6. PubMed ID: 9667146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
